Background {#Sec1}
==========

Fournier's gangrene (FG) is a devastating necrotising disease that affects the perineum and genitourinary regions. The common cause of FG is poly-microbial infections, where the diabetes mellitus is an attributing common risk factor (Shyam and Rapsang \[[@CR19]\]). Study has shown that males, especially in their 60 to 70s, are more often affected by FG when compared to other populations (Rodríguez Alonso et al. \[[@CR15]\]). Aside from diabetes, other risk factors of FG also include chronic alcoholism, renal failure, and obesity (Montoya Chinchilla et al. \[[@CR12]\]). The majorities of FG studies have shown that early diagnosis and aggressive management of FG are required to significantly improve patient outcome. Due to the fact that FG is not a common disease, a prospective study is difficult to perform. Therefore, In this study, a large number of FG cases that have occurred in the past five years are gathered by retrospective literature review and analyzed to determined the relationship between micrology and prognosis of FG.

Methods {#Sec2}
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A retrospective cohort study was designed to investigate the correlation between micrology and prognosis of FG. A search from the PubMed database returned a total of 1,015 literatures that contain the keyword "Fournier's gangrene". The resulting literatures were further limited to the literature s that were published within the past 5 years, (from Jan.1, 2009 to Dec 31, 2013), where a total of 330 articles remained. The articles that contain case numbers of less than 30 were excluded from the study, since the low sample number cannot establish a normal distribution for the evaluation of statistical significance. In the end, there were 19 articles that was enrolled into this study. The combined data and descriptions of Fournier's gangrene are listed in Table. [1](#Tab1){ref-type="table"} References (Martinschek et al. \[[@CR10]\]) to (Ersoz et al. \[[@CR5]\]). These enrolled research literatures are from Germany (n = 4, 21%), Turkey (n = 4), United States of America (n = 2), Pakistan (n = 2), Spain (n = 2), Mexico (n = 1), Brazil (n = 1), Taiwan (n = 1), Tunisia (n = 1) and Croatia (n = 1). The data was analyzed with a commercial statistical software (SPSS for Windows, version 11.0, SPSS Ltd., Chicago, IL). Statistical χ2 tests were performed and the significance was set at a p value of less than 0.05 (2-tailed).Table 1**There were 19 articles (from January 1, 2009 to December 31, 2013) enrolled into this study**DurationDuration \[years\]First authorCountryNumberMale %Female %Mean ageMortality rate %1981 \~ 201029Martinschek et al. (\[[@CR10]\])Germany5561.838.24816.41994 \~ 200612Macro et. al. (\[[@CR8]\])Spain5194663161995 \~ 201015Sallami et a. (\[[@CR18]\])Tunisia40NANA52.817.51995 \~ 201015Altarac et al. (\[[@CR1]\])Croatia419556236.61996 \~ 200610Yilmazlar et al. (\[[@CR23]\])Turkey8071.328.757211996 \~ 200610Ozturk et al. (\[[@CR14]\])Turkey4452.347.75736.31996 \~ 200812Czymek et al. (\[[@CR4]\])Germany38NANA57.721.11998 \~ 20068MEHL et al. (\[[@CR11]\])Brazil40772347.2201999 \~ 200910Koukouras et al. (\[[@CR7]\])Germany4588.911.15015.62000 \~ 20088Malik et al. (\[[@CR9]\])Pakistan7391.88.257.317.82000 \~ 20088Chen et al. (\[[@CR3]\])Taiwan50NANA53.6122001 \~ 20044Sorensen et al. (\[[@CR20]\])USA168097.72.350.97.52001 \~ 201110Roghmann et al. (\[[@CR16]\])Germany44NANA59302002 \~ 20075Morua et al. (\[[@CR13]\])Mexico6396447.5122002 \~ 20075Ullah et al. (\[[@CR21]\])Pakistan6083.316.74772003 \~ 20085Vargas et al. (\[[@CR22]\])Spain42100051172004 \~ 201036GÖKTAŞ et al. (\[[@CR6]\])Turkey36NANA55.511.12004 \~ 20117Bjurlin et al. (\[[@CR2]\])USA12297.62.4494.92005 \~ 20083Ersoz et al. (\[[@CR5]\])Turkey5269315523.8The combined data and descriptions of Fournier's gangrene are listed in Table 1.NA = Not Available.
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The twenty-two studies have covered FG cases from year 1981 to 2011, with a mean duration of 9.2 years. The total number of cases is 2,656. Majority of cases are male (84.1%) and female is accounted for 15.9%.

The mean age of the patients is 51.8 years old, and the average mortality rate is 11.1 ± 8.9%. When comparing between the older age group (age \> 51.8 years old) and the younger group (age of less or equal to 51.8), the mortality rate was found to be higher in the older group than younger (22 ± 8.8% versus 5.5 ± 2%, *p* = *0.0001*) The most commonly found pathogen is poly-microbial organism (54%), followed by *Escherichia coli* (46.6%) and *Streptococcus* (36.8%). The other contributing pathogens also include *Bacteroides*, *Enterbacter*, *Staphylococcus*, *Enterococcus*, *Pseudomonas*, *Corynebacterium*, and *Klebsiella pneumoniae* (Figure [1](#Fig1){ref-type="fig"}).Figure 1**List of commonly found pathogens involving Fournier'** **s gangrene** **(presented in percentages).**

The major risk factors for FG are diabetes (43.7%), body mass index of higher than 30 (40.7%), and hypertension (38.1%). Other risk factors also include heart disease (38%), alcoholism (31.4%), smoking (22.5%), renal failure (13.8%), urethral operation history, neurogenic bladder, and corticosteroid user (Figure [2](#Fig2){ref-type="fig"}).Figure 2**List of commonly found risk factors involving Fournier'** **s gangrene** **(presented in percentages).**
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Fournier's gangrene (FG) is a rare emergent condition that affects the perineum and urogenital region. The clinical course of FG is fulminant and serious regardless of parenteral antibiotic treatment. The median time from syptom presentations to skin gangrenous change is 6 days (Altarac et al. \[[@CR1]\]). When managing FG patients, this gangrenous tissue requires extensive and repeated debridement (Sallami et al. \[[@CR18]\]). Several literatures have shown that patients with diabetes, old age, low blood pressure, high creatine kinase, high lactate, abdominal affection, hemoglobin of less than 10 g/dL, and platelet count of less than 150 × 10^9^/L are associated with poor outcomes (Martinschek et al. \[[@CR10]\]; Ruiz-Tovar et al. \[[@CR17]\]).

Many literatures have determined that the risk factors of FG include diabetes mellitus, hypertension, heart disease, smoking, long-term steroid therapy, alcoholism or alcohol abuse, in hot and humid season, and renal failure (Martinschek et al. \[[@CR10]\]; Sallami et al. \[[@CR18]\]; Czymek et al. \[[@CR4]\]; Mehl et al. \[[@CR11]\]; Malik et al. \[[@CR9]\]; Ullah and Khan \[[@CR21]\]). Out of the many risk factors, diabetes mellitus is still the highest influencing factor on FG where 43.7% of FG patients are diabetic. A report by Czymek et. al. showed that being overweight is also a risk factor of FG, where nearly 40 % of FG patients have body mass indexes (BMIs) of higher than 30 (Czymek et al. \[[@CR4]\]; Mehl et al. \[[@CR11]\]). Although there are several known risk factors that can lead to the development of FG, the clinical onset of FG is still unpredictable.

The most common symptoms of FG are perineal pain and fever that are accompanied by swelling and reddening of perineum or genital area, and the gangreneous change of overlaying skin (Ruiz-Tovar et al. \[[@CR17]\]).

The most common microbiology involved in FG is poly-microbial infection (54%), and the most common found pathogen isolate is *Escherichia coli* (46.6%). Others contributing pathogen are *Streptococcal infection*, *Bacteroides*, *Enterobacter*, *Staphylococcus*, *Enterococcus*, *Pseudomonas*, *Corynebacterium*, *and Klebsiella pneumoniae* (Rodríguez Alonso et al. \[[@CR15]\]; Czymek et al. \[[@CR4]\]; Mehl et al. \[[@CR11]\]). Broad-spectrum antibiotic treatment is suggested to adequately cover poly-microbial pathogen, and careful patient monitoring is required to avoid is fungal or hospital-acquired pathogen infection (Bjurlin et al. \[[@CR2]\]).

In terms of gender, there was no significant mortality rate that was found between the genders (Ersoz et al. \[[@CR5]\]). A study from Spain (n = 51) showed that the survivors of FG are 13.5 years younger than those who have died (60 versus 73.5, *p* = *0.02*) (Luján Marco et al. \[[@CR8]\]). In a 2012 report from Turkey ( n = 52), the non-survivors group are older in age than survivors (62 versus 55 years old\]. In our study, the results also showed that the older patients age had higher rates of mortality. This result is concurrent with in the other previous studies, where increased age was shown to be related to higher mortality rate (Martinschek et al. \[[@CR10]\]; Roghmann et al. \[[@CR16]\]).

Although FG is rare, its rapid progression can lead to life-threatening conditions that require early surgical intervention and parenteral antibiotics to improve patient outcomes (Morua et al. \[[@CR13]\]). The mortality rate of FG remains high and ranges from 4.9 to 36.6% in the recent five years. Due to its high mortality rate and rapid progress, FG must be regarded in clinical settings. The reduction of obesity, alcohol consumption, tobacco use is helpful in reducing the possible risk of FG. Furthermore, older patients with genital or perineal pain should be examined for crepitus dermis. Finally, when a patient is diagnosed with FG, swift consultation with surgeons and administration of broad-spectrum antibiotics are required in order to save the patient's live.
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